Maxtec, Inc. – Trademark Portfolio
Entity Type: 03
Maxtec, Inc. holds 16 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 12 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 4 Nice Classification classes. Currently, 7 trademarks are registered. Notable registered marks include HANDI, MAXO2+, MAXTEC, AGILETICS, and MAXVENTURI. The owner is based in Salt Lake City, UT.
6526 South Cottonwood Street
Salt Lake City, UT 84107
Showing of trademarks Trademarks
Trademark Classifications
Maxtec, Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Maxtec, Inc. have?
Maxtec, Inc. has 16 U.S. trademarks filed with the USPTO. Of these, 7 registered, 4 abandoned, 5 cancelled.
What trademark classes does Maxtec, Inc. file in?
Maxtec, Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 35 (Advertising & Business), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are Maxtec, Inc.'s most well-known trademarks?
Maxtec, Inc.'s registered trademark portfolio includes well-known marks such as HANDI, MAXO2+, MAXTEC, AGILETICS, and MAXVENTURI. These are among 7 currently registered trademarks in the portfolio.
What is Maxtec, Inc.'s trademark registration success rate?
Maxtec, Inc. has a 44% trademark registration rate, with 7 out of 16 resolved applications resulting in successful registration. Currently, 0 applications are pending review.